Skip to main content
  •   

    How Effective Is Anti-ANG2 and Anti-VEGF for Neovascular AMD With Persistent Epithelial Defects?

    Retina Subspecialty Day 2023
    Retina/Vitreous

    In this presentation from Retina Subspecialty Day 2023, Dr. Lim presents the findings from the study that compared the effectiveness of anti-ANG2 versus anti-VEGF in patients with neovascular AMD with PED.